These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 37380638)
1. Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway. Yang W; Pan L; Cheng Y; Wu X; Huang S; Du J; Zhu H; Zhang M; Zhang Y Sci Rep; 2023 Jun; 13(1):10485. PubMed ID: 37380638 [TBL] [Abstract][Full Text] [Related]
2. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice. Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579 [TBL] [Abstract][Full Text] [Related]
3. Potential "Therapeutic" Effects of Tocotrienol-Rich Fraction (TRF) and Carotene "Against" Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways. Lu Y; Zhang Y; Pan Z; Yang C; Chen L; Wang Y; Xu D; Xia H; Wang S; Chen S; Hao YJ; Sun G Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268069 [TBL] [Abstract][Full Text] [Related]
4. Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway. Li X; Ma X; Miao Y; Zhang J; Xi B; Li W; Zhang Q; Chen L; Yang Y; Li H; Wei L; Zhou H; Yang C J Cell Mol Med; 2023 Feb; 27(3):422-434. PubMed ID: 36651446 [TBL] [Abstract][Full Text] [Related]
5. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment]. Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559 [TBL] [Abstract][Full Text] [Related]
6. Essential oil from Inula japonica Thunb. And its phenolic constituents ameliorate pulmonary injury and fibrosis in bleomycin-treated mice. Wei F; Yin Y; Li J; Chang Y; Zhang S; Zhao W; Ma X J Ethnopharmacol; 2024 Jan; 319(Pt 1):117169. PubMed ID: 37704119 [TBL] [Abstract][Full Text] [Related]
7. Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/Akt signaling in mice. Hussein RM; Arafa EA; Raheem SA; Mohamed WR Life Sci; 2023 Feb; 314():121256. PubMed ID: 36549352 [TBL] [Abstract][Full Text] [Related]
8. Ketogenic diet induces autophagy to alleviate bleomycin-induced pulmonary fibrosis in murine models. Mu E; Wang J; Chen L; Lin S; Chen J; Huang X Exp Lung Res; 2021 Feb; 47(1):26-36. PubMed ID: 33121292 [TBL] [Abstract][Full Text] [Related]
9. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Lu Y; Zhong W; Liu Y; Chen W; Zhang J; Zeng Z; Huang H; Qiao Y; Wan X; Meng X; Cai S; Dong H Int Immunopharmacol; 2022 Mar; 104():108504. PubMed ID: 35026657 [TBL] [Abstract][Full Text] [Related]
10. Revealing the mechanism of Jiegeng decoction attenuates bleomycin-induced pulmonary fibrosis via PI3K/Akt signaling pathway based on lipidomics and transcriptomics. Xu Y; Wang X; Han D; Wang J; Luo Z; Jin T; Shi C; Zhou X; Lin L; Shan J Phytomedicine; 2022 Jul; 102():154207. PubMed ID: 35660351 [TBL] [Abstract][Full Text] [Related]
11. Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis. Wu W; Wu X; Qiu L; Wan R; Zhu X; Chen S; Yang X; Liu X; Wu J Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4809-4822. PubMed ID: 38153514 [TBL] [Abstract][Full Text] [Related]
12. Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway. Fang L; Chen H; Kong R; Que J Life Sci; 2020 Nov; 260():118399. PubMed ID: 32918977 [TBL] [Abstract][Full Text] [Related]
13. Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways. Wanas H; El Shereef Z; Rashed L; Aboulhoda BE Curr Mol Pharmacol; 2022; 15(1):227-238. PubMed ID: 33563204 [TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt signaling is involved in the pathogenesis of bleomycin‑induced pulmonary fibrosis via regulation of epithelial‑mesenchymal transition. Zhang XL; Xing RG; Chen L; Liu CR; Miao ZG Mol Med Rep; 2016 Dec; 14(6):5699-5706. PubMed ID: 27878273 [TBL] [Abstract][Full Text] [Related]
15. Jingfang Granules () alleviates bleomycin-induced acute lung injury through regulating PI3K/Akt/mTOR signaling pathway. Sun X; Xiang H; Liu Z; Xiao H; Li X; Gong W; Pan L; Zhao L; Yao J; Sun C; Zhang G J Ethnopharmacol; 2024 Jan; 318(Pt A):116946. PubMed ID: 37482261 [TBL] [Abstract][Full Text] [Related]
16. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression. Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607 [TBL] [Abstract][Full Text] [Related]
17. Deficiency of Psgl-1 accelerates bleomycin (BLM)-induced lung fibrosis and inflammation in mice through activating PI3K/AKT. Han X; Wang SM Biochem Biophys Res Commun; 2017 Sep; 491(2):558-565. PubMed ID: 28263743 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Tashiro J; Elliot SJ; Gerth DJ; Xia X; Pereira-Simon S; Choi R; Catanuto P; Shahzeidi S; Toonkel RL; Shah RH; El Salem F; Glassberg MK Transl Res; 2015 Dec; 166(6):554-67. PubMed ID: 26432923 [TBL] [Abstract][Full Text] [Related]
19. Fluorofenidone attenuates paraquat‑induced pulmonary fibrosis by regulating the PI3K/Akt/mTOR signaling pathway and autophagy. Jiang F; Li S; Jiang Y; Chen Z; Wang T; Liu W Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33786626 [TBL] [Abstract][Full Text] [Related]
20. PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo. Sun HN; Ren CX; Lee DH; Wang WH; Guo XY; Hao YY; Wang XM; Zhang HN; Xiao WQ; Li N; Cong J; Han YH; Kwon T Cell Mol Biol Lett; 2023 Jun; 28(1):48. PubMed ID: 37268886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]